BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27127130)

  • 1. Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.
    Hsu CM; Lin PM; Lin HC; Lai CC; Yang CH; Lin SF; Yang MY
    Anticancer Res; 2016 May; 36(5):2251-8. PubMed ID: 27127130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
    Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
    Zhang X; Hunt JL; Shin DM; Chen ZG
    Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.
    Wang D; Grecula JC; Gahbauer RA; Schuller DE; Jatana KR; Biancamano JD; Lang JC
    Oncol Rep; 2006 Mar; 15(3):661-5. PubMed ID: 16465427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
    Esteves LI; Javaroni AC; Nishimoto IN; Magrin J; Squire JA; Kowalski LP; Rainho CA; Rogatto SR
    Mol Carcinog; 2005 Oct; 44(2):102-10. PubMed ID: 16015666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
    Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
    Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia.
    Yang MY; Lin PM; Yang CH; Hu ML; Chen IY; Lin SF; Hsu CM
    Blood Cells Mol Dis; 2021 Sep; 90():102577. PubMed ID: 34091126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
    Lawson EA; Zhang X; Crocker JT; Wang WL; Klibanski A
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2226-31. PubMed ID: 19383775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
    Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
    Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
    Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
    Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
    Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.